Healthcare Asia Magazine on MSN
A*STAR disarms pathway protecting lung cancer cells
The discovery addresses resistance amongst patients after one to two years of treatment. Researchers at Agency for Science, ...
Figure 6: Mechanism of Anti-EGFR resistance in head and neck cancer by activation of TLR4-MyD88 signaling. EGFR inhibition by cetuximab prevents Src activation, thus preventing MyD88 degradation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results